These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2140730

  • 41. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI, Semin IuA, Petrova KM, Kutmin AI.
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [Abstract] [Full Text] [Related]

  • 42. Oncogenic transforming potential of nitroimidazole radiosensitizers.
    Hall EJ, Hei TK.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
    [Abstract] [Full Text] [Related]

  • 43. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K, Takahashi M, Hamanaka D, Hiraoka M, Nishidai T, Abe M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb 25; 43(2):370-6. PubMed ID: 6223274
    [No Abstract] [Full Text] [Related]

  • 44. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 25; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 45. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul 25; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 46. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses.
    Shibata T, Shibamoto Y, Oya N, Sasai K, Murata R, Ishigaki T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):587-90. PubMed ID: 8005820
    [Abstract] [Full Text] [Related]

  • 47. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
    Stratford IJ, Hickson ID, Robson CN, Stephens M.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1307-10. PubMed ID: 2523884
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics of fluorinated 2-nitroimidazole hypoxic cell radiosensitizers in murine peripheral nervous tissue.
    Sasai K, Iwai H, Yoshizawa T, Nishimoto S, Shibamoto Y, Kitakabu Y, Oya N, Takahashi M, Abe M.
    Int J Radiat Biol; 1992 Aug 15; 62(2):221-7. PubMed ID: 1355516
    [Abstract] [Full Text] [Related]

  • 49. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
    Oya N, Shibamoto Y, Shibata T, Murata R, Iwai H, Sugiyama T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):595-600. PubMed ID: 8005822
    [Abstract] [Full Text] [Related]

  • 50. Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissue.
    Sasai K, Shibamoto Y, Takahashi M, Ito T, Nishimoto S, Abe M.
    Int J Radiat Biol; 1990 May 15; 57(5):971-80. PubMed ID: 1970998
    [Abstract] [Full Text] [Related]

  • 51. Hypoxia-specific inhibition of recovery from radiation damage by a novel 2-nitroimidazole with a theophylline side chain.
    Hodgkiss RJ, Kelleher E, Parrick J.
    Int J Radiat Biol; 1992 Jun 15; 61(6):797-803. PubMed ID: 1351530
    [Abstract] [Full Text] [Related]

  • 52. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M, Hall EJ.
    Br J Cancer; 1979 May 15; 39(5):510-5. PubMed ID: 486306
    [Abstract] [Full Text] [Related]

  • 53. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I, Stratford IJ, Jenkins TC.
    Arzneimittelforschung; 1985 May 15; 35(12):1763-8. PubMed ID: 4096727
    [Abstract] [Full Text] [Related]

  • 54. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb 15; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 55. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S.
    Br J Cancer Suppl; 1978 Jun 15; 3():212-5. PubMed ID: 277230
    [Abstract] [Full Text] [Related]

  • 56. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A, Smith KA, Soranson JA, Minchinton AI, Middleton RW, Denekamp J.
    Radiother Oncol; 1984 Dec 15; 2(4):325-32. PubMed ID: 6522642
    [Abstract] [Full Text] [Related]

  • 57. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
    Shrieve DC, Harris JW.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jul 15; 48(1):127-38. PubMed ID: 3159699
    [Abstract] [Full Text] [Related]

  • 58. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
    Denny WA, Roberts PB, Anderson RF, Brown JM, Phil D, Wilson WR.
    Int J Radiat Oncol Biol Phys; 1992 Jul 15; 22(3):553-6. PubMed ID: 1735695
    [Abstract] [Full Text] [Related]

  • 59. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH, Wallen CA, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1990 May 15; 18(5):1043-50. PubMed ID: 2140824
    [Abstract] [Full Text] [Related]

  • 60. Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles.
    Santus R, Stobbe CC, McPhee MS, Chapman JD.
    Radiat Res; 1992 Apr 15; 130(1):31-7. PubMed ID: 1532856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.